CHIMPs: Implementation and Evaluation of a Family-based Intervention Program for Children of Mentally Ill Parents

Sponsor
Silke Wiegand-Grefe, Prof. Dr. (Other)
Overall Status
Completed
CT.gov ID
NCT02308462
Collaborator
Universitätsklinikum Hamburg-Eppendorf (Other), University of Ulm (Other), Universitätsklinikum Leipzig (Other), LWL-Klinikum Gütersloh (Other), Vitos Klinik Rheinhöhe (Other), Charite University, Berlin, Germany (Other), Cantonal Hospital Winterthur, Switzerland (Other)
400
14
2
55
28.6
0.5

Study Details

Study Description

Brief Summary

In order to identify psychological stress in children and adolescents of mentally ill parents as early as possible, a special intervention program (CHIMPs = Children of mentally ill parents) was developed. The study at hand will implement this intervention program at five sites in Germany and will further evaluate its effectiveness. The CHIMPs intervention is assumed to reduce children's psychopathology and enhance their health related quality of life.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: CHIMPS intervention
N/A

Detailed Description

The main purpose of this study is to implement the manualized family intervention CHIMPs (Children of mentally ill parents) for children and adolescents of psychiatrically ill parents aged between 3 and 19 years at the seven participating centres in regular care. The intervention aims at reducing children's psychopathology and enhancing their quality of life in a sustainable way and, moreover, aims at introducing especially remarkable children and adolescents to an early intervention.

The study represents a prospective, randomized and controlled multicenter study (RCT), contrasting one intervention group and one control group (TAU = Treatment as usual) by measurements at baseline and after six, 12 and 18 months. Within the data collection, the perspective of the psychiatrically ill parent, the partner, each child and the therapist will be considered. Children between 3 and 9 years of age will be evaluated only by the parents and the therapist, from 10 years on, an additional self-report form will be filled out by the child. The measurement will be ruled out indirectly (for the pre-post-measurement) as well as directly (at the end of treatment).

For each endpoint, one comprehensive mixed model will be fitted to the data containing the baseline value and further relevant patient characteristics as covariates, the random group as factor and cluster (center, therapy group, family) as random effect. Missing values will be treated by direct imputation to allow an intention-to-treat analysis.

Study Design

Study Type:
Interventional
Actual Enrollment :
400 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Implementation and Evaluation of a Family-based Intervention Program for Children and Adolescents of Mentally Ill Parents - a Randomized Controlled Multicenter Trial
Study Start Date :
Nov 1, 2014
Actual Primary Completion Date :
Jun 1, 2019
Actual Study Completion Date :
Jun 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: CHIMPs intervention

Family-Intervention

Behavioral: CHIMPS intervention
CHIMPs intervention (Family-Intervention composed of 8 Topic-related sessions over a period of 6 month, based on the evaluated manual: a preliminary talk with the family, two sessions with the parents, one session with each child, three sessions with the family). The sessions are semi-structured and cover the topics illness and coping, education, family relationships and trusting attachement figures, social network and support of the Family. A detailed description of the procedure is found in the Manual (Wiegand-Grefe, Halverscheid & Plass, 2011).

No Intervention: Control

The long-term effectiveness of the CHIMPs intervention under conditions of practice will be examined in comparison to a control condition receiving the usual after care (Treatment as usual = TAU); this testing of effectiveness will be performed in due consideration of the health economic aspects. The treatment as usual implies that families of the control Group receive the Treatment that is customary in regular care. Thus, these families normally don't receive any post-treatment. If, however, a member of a control group family appears to have an urgent need for treatment (every Family receives a comprehensive diagnostic investigation at the beginning of the study), the respective family will be placed in the ambulatory care system.

Outcome Measures

Primary Outcome Measures

  1. children's psychiatric symptomatology (Kiddie-SADS interview) [at the beginning of the study (on study enrolment)]

    Children's psychiatric symptomatology will be assessed, in both groups (Intervention group and control group), by an external Independent interview (Kiddie-SADS, Kaufman et al., 1996). The Kiddie-SADS interview will be conducted by a trained rater external to the project (observer-blind rater).

  2. children's psychiatric symptomatology (Child behaviour checklist) [at the beginning of the study (on study enrolment)]

    The psychiatric disorders of the children will further be assessed by the CBCL ("Child behaviour checklist", Achenbach, 1991),

  3. children's psychiatric symptomatology (assessed by Youth Self Report) [at the beginning of the study (on study enrolment)]

    The psychiatric disorders of the children will further be assessed by the YSR ("Youth self Report", Achenbach, 1991)

  4. children's psychiatric symptomatology (assessed by the SGKJ) [at the beginning of the study (on study enrolment)]

    The psychiatric disorders of the children will further be assessed by the SGKJ ("Skala zur Gesamtbeurteilung von Kindern und Jugendlichen", a scale for the overall assessment of children and adolescents, Steinhausen, 1985).

  5. children's psychiatric symptomatology (Kiddie-SADS interview) [after the treatment (after 6 months)]

    Children's psychiatric symptomatology will be assessed, in both groups (Intervention group and control group), by an external Independent interview (Kiddie-SADS, Kaufman et al., 1996). The Kiddie-SADS interview will be conducted by a trained rater external to the project (observer-blind rater).

  6. children's psychiatric symptomatology (Kiddie-SADS interview) [after the follow-up period (after 18 months)]

    Children's psychiatric symptomatology will be assessed, in both groups (Intervention group and control group), by an external Independent interview (Kiddie-SADS, Kaufman et al., 1996). The Kiddie-SADS interview will be conducted by a trained rater external to the project (observer-blind rater).

  7. children's psychiatric symptomatology (Child behaviour checklist) [after the treatment (after 6 months)]

    The psychiatric disorders of the children will further be assessed by the CBCL ("Child behaviour checklist", Achenbach, 1991),

  8. children's psychiatric symptomatology (Child behaviour checklist) [after the follow-up period (after 18 months)]

    The psychiatric disorders of the children will further be assessed by the CBCL ("Child behaviour checklist", Achenbach, 1991),

  9. children's psychiatric symptomatology (assessed by Youth Self Report) [after the treatment (after 6 months)]

    The psychiatric disorders of the children will further be assessed by the YSR ("Youth self Report", Achenbach, 1991)

  10. children's psychiatric symptomatology (assessed by Youth Self Report) [after the follow-up period (after 18 months)]

    The psychiatric disorders of the children will further be assessed by the YSR ("Youth self Report", Achenbach, 1991)

  11. children's psychiatric symptomatology (assessed by the SGKJ) [after the treatment (after 6 months)]

    The psychiatric disorders of the children will further be assessed by the SGKJ ("Skala zur Gesamtbeurteilung von Kindern und Jugendlichen", a scale for the overall assessment of children and adolescents, Steinhausen, 1985).

  12. children's psychiatric symptomatology (assessed by the SGKJ) [after the follow-up period (after 18 months)]

    The psychiatric disorders of the children will further be assessed by the SGKJ ("Skala zur Gesamtbeurteilung von Kindern und Jugendlichen", a scale for the overall assessment of children and adolescents, Steinhausen, 1985).

Secondary Outcome Measures

  1. children's health related quality of life (Kidscreen) [at the beginning (on study enrolment) and at the end of the intervention (after 6 months) as well as after the follow-up period (after 18 months)]

    Kidscreen (Ravens-Sieberer et al., 2006)

  2. parents' health related quality of life (EQ-5D) [at the beginning (on study enrolment) and at the end of the intervention (after 6 months) as well as after the follow-up period (after 18 months)]

    EQ-5D (Brooks, Rabon & de Charro, 2003; Hinz, Klaiberg, Brähler & König, 2006)

  3. Symptomatology of the parents (Brief Symptom Inventory) [at the beginning (on study enrolment) and at the end of the intervention (after 6 months) as well as after the follow-up period (after 18 months)]

    Brief Symptom Inventory (Franke, 2000)

  4. Symptomatology of the parents (only Intervention group) (SKID; a structured clinical interview for DSM-IV) [during CHIMPs intervention]

    Strukturiertes Klinisches Interview für DSM-IV (SKID; a structured clinical interview for DSM-IV, Wittchen, Zaudig & Fydrich, 1997)

  5. parents' coping with the disorder (Freiburger Fragebogen zur Krankheitsbewältigung) [at the beginning (on study enrolment) and at the end of the intervention (after 6 months) as well as after the follow-up period (after 18 months)]

    Freiburger Fragebogen zur Krankheitsbewältigung (FKV; Muthny, 1989)

  6. family relations (children and parents) (Allgemeiner Familienfragebogen) [at the beginning (on study enrolment) and at the end of the intervention (after 6 months) as well as after the follow-up period (after 18 months)]

    Allgemeiner Familienfragebogen (FB-A;Cierpka & Frevert, 1995)

  7. Social Support (Oslo Social Support Questionnaire) [at the beginning (on study enrolment) and at the end of the intervention (after 6 months) as well as after the follow-up period (after 18 months)]

    Oslo Social Support Questionnaire (OSSQ; Dalgaard, 1996)

  8. Objectives of the treatment (children and parents) [at the beginning of the study (on study enrolment)]

    Objective of the treatment, assessed by the item "What could be the main objective of a possible treatment?"

  9. achievement of the objectives of the treatment (children and parents) [at the end of the intervention (after 6 months) as well as after the follow-up period (after 18 months)]

    achievement of the objectives of the treatment, assessed by the item "Did you achieve the main objective of your treatment?" and by the item "Taken as a whole, did the family sessions help you?"

  10. Evaluation of the Treatment (children and parents) (Fragebogen zur Beurteilung der Behandlung) [at the end of the intervention (after 6 months) as well as after the follow-up period (after 18 months)]

    Fragebogen zur Beurteilung der Behandlung (FBB; Mattejat & Remschmidt, 1999)

  11. health economic assessment of treatment costs (children) (German version of the "Children and adolescent mental health Services receipt inventory) [at the beginning (on study enrolment), at the end of treatment (after 6 months), after 12 months and after the follow-up period (after 18 months)]

    German version of the Children and adolescent mental health Services receipt inventory" (CAMHSRI; Kilian et al., 2009)

  12. health economic assessment of treatment costs (parents) (German version of the Client Socioeconomic and Services Receipt Inventory) [at the beginning (on study enrolment), at the end of treatment (after 6 months), after 12 months and after the follow-up period (after 18 months)]

    German version of the "Client Socioeconomic and Services Receipt Inventory" (CSSRI; Roick et al., 2001)

  13. Symptomatology of the parents [at the beginning (on study enrolment)]

    German version of the "Patient Health Questionnaire" (PHQ; Löwe, Spitzer, Zipfel & Herzog, 2002)

Eligibility Criteria

Criteria

Ages Eligible for Study:
3 Years to 19 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Family with at least one psychiatrically ill parent and at least one child between the age of 3 and 19 years

  • Consent to participate in the study

  • Sufficient knowledge of the German language of parents and children

Exclusion Criteria:
  • Severe psychiatric disorders and impairments with acute symptoms such as suicidal tendencies, massive self-injurious behaviour, acute psychotic symptoms etc., making a stationary treatment inevitable and making a ambulatory intervention appear contraindicated (These patients are placed in stationary treatment)

  • Children with severe symptoms in the control group will be placed at a participating psychotherapist. Nevertheless, they stay in the control group (as TAU).

Contacts and Locations

Locations

Site City State Country Postal Code
1 Charité Campus Virchow Klinikum, Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters Berlin Germany
2 Vitos psychiatrische Ambulanz Eltville Eltville Germany
3 Bezirkskrankenhaus Günzburg, Klinik für Psychiatrie, Psychotherapie und Psychosomatik Günzburg Germany
4 LWL-Klinikum Gütersloh, Klinik für Allgemeine Psychiatrie und Psychotherapie Gütersloh Germany
5 Asklepios Klinikum Harburg Hamburg-Harburg Germany
6 Schön Klinik Hamburg Eilbek, Abteilung für Psychiatrie und Psychotherapie Hamburg Germany
7 University Medical Center Hamburg-Eppendorf, Clinic and Polyclinic for psychiatry and psychotherapy Hamburg Germany
8 Vitos psychiatrische Ambulanzen Idstein Idstein Germany
9 Universitätsklinikum Leipzig, Klinik für Psychiatrie, Psychotherapie und Psychosomatik des Kindes- und Jugendalters Leipzig Germany
10 Universitätsklinkum Leipzig, Klinik und Poliklinik für Psychiatrie und Psychotherapie Leipzig Germany
11 LWL-Klinik Paderborn, Allgemeine Psychiatrie und Psychotherapie Paderborn Germany
12 Klinik für Psychiatrie und Psychotherapie des Sächsischen Krankenhauses Altscherbitz Schkeuditz Germany
13 Vitos psychiatrische Tageskliniken Wiesbaden Wiesbaden Germany
14 Centre of Social Pediatrics, Dept. of Pediatrics and Adolescent Medicine Winterthur Switzerland

Sponsors and Collaborators

  • Silke Wiegand-Grefe, Prof. Dr.
  • Universitätsklinikum Hamburg-Eppendorf
  • University of Ulm
  • Universitätsklinikum Leipzig
  • LWL-Klinikum Gütersloh
  • Vitos Klinik Rheinhöhe
  • Charite University, Berlin, Germany
  • Cantonal Hospital Winterthur, Switzerland

Investigators

  • Principal Investigator: Silke Wiegand-Grefe, Prof., Universitätsklinikum Hamburg-Eppendorf

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Silke Wiegand-Grefe, Prof. Dr., Professor of clinical psychology, Universitätsklinikum Hamburg-Eppendorf
ClinicalTrials.gov Identifier:
NCT02308462
Other Study ID Numbers:
  • O1GY1337
  • U1111-1162-2635
  • DRKS00006806
First Posted:
Dec 4, 2014
Last Update Posted:
Jul 20, 2020
Last Verified:
Jul 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Keywords provided by Silke Wiegand-Grefe, Prof. Dr., Professor of clinical psychology, Universitätsklinikum Hamburg-Eppendorf
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 20, 2020